Long-term adherence to antiosteoporosis medication (AOM) in the setting of a fracture liaison service (FLS) is not well known. Patients ≥ 50 with hip fractures seen in an FLS and recommended for treatment to prevent new fractures were analyzed.
Source: scientific reports